Trump Civil Trial, Genocide Case Against Israel, A New Way to Invest in Bitcoin

This podcast episode explores pivotal legal events, including the legal battles faced by former President Trump, a genocide case brought against Israel by South Africa, the green light for Bitcoin ETFs in the US, and the SEC's push to mitigate risks in the crypto industry.

Outlines

Sign in to continue reading, translating and more.

Open full episode in Podwise

Up First from NPR

Up First: Bitcoin Funds Approved, Israel Genocide Allegations, and Carvana Value Tracker

Trump's Business Practices Trial: Closing Arguments and Potential Consequences

Trump's Legal Battles and the Republican Presidential Nomination

International Court of Justice Hears South Africa's Case Against Israel for Alleged Genocide in Gaza

Bitcoin ETFs: A New Era for Cryptocurrency Investment

Navigating the Complexities of Bitcoin ETFs: A Discussion on Legality, Risks, and Regulatory Oversight

Trump Civil Trial, Genocide Case Against Israel, A New Way to Invest in Bitcoin

Up First from NPR

00:00Up First: Bitcoin Funds Approved, Israel Genocide Allegations, and Carvana Value Tracker

Up First: Bitcoin Funds Approved, Israel Genocide Allegations, and Carvana Value Tracker

01:28Trump's Business Practices Trial: Closing Arguments and Potential Consequences

Trump's Business Practices Trial: Closing Arguments and Potential Consequences

03:39Trump's Legal Battles and the Republican Presidential Nomination

Trump's Legal Battles and the Republican Presidential Nomination

05:33International Court of Justice Hears South Africa's Case Against Israel for Alleged Genocide in Gaza

International Court of Justice Hears South Africa's Case Against Israel for Alleged Genocide in Gaza

09:17Bitcoin ETFs: A New Era for Cryptocurrency Investment

Bitcoin ETFs: A New Era for Cryptocurrency Investment

11:10Navigating the Complexities of Bitcoin ETFs: A Discussion on Legality, Risks, and Regulatory Oversight

Navigating the Complexities of Bitcoin ETFs: A Discussion on Legality, Risks, and Regulatory Oversight